Bowen Acquisition Corp.

12/12/2025 | Press release | Distributed by Public on 12/12/2025 16:01

Proxy Results (Form 8-K)

Item 5.07. Submission of Matters to a Vote of Security Holders.

On December 12, 2025, Bowen Acquisition Corp (the "Company") held an extraordinary general meeting (the "Meeting") to approve, by special resolution and pursuant to the terms of the Company's amended and restated memorandum and articles of association, as amended (the "Articles"), an amendment to the Articles to allow the board of directors of the Company (the "Board") to extend the date (the "Extension") by which the Company must consummate an initial merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (a "business combination").

An aggregate of 2,616,701 ordinary shares of the Company, which represented a quorum of the outstanding ordinary shares entitled to vote as of the record date of November 12, 2025, were represented in person or by proxy at the Meeting.

The Company's shareholders voted on the following proposal at the Meeting, which was approved:

(1) Proposal No. 1 - The Extension Proposal - a proposal to amend the Company's Articles to extend the date by which the Company has to consummate a business combination by up to three one-month increments, from December 14, 2025 to as late as June 14, 2026, unless the closing of a business combination shall have occurred prior thereto or such earlier date as shall be determined by the Board in its sole discretion. The following is a tabulation of the votes with respect to this proposal:
For Against Abstain Broker Non-Votes
2,612,224 4,477 0 0

The amendments to the Amended and Restated Memorandum and Articles of Association of the Company to be filed with the Cayman Islands Registrar of Companies to effectuate the Extension are attached hereto as Exhibit 3.1.

The Company is continuing to attempt to satisfy the remaining conditions to closing its proposed business combination with Shenzhen Qianzhi BioTechnology Co. Ltd.

Bowen Acquisition Corp. published this content on December 12, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on December 12, 2025 at 22:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]